X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-04-02 | SGHT | Sight Sciences, Inc. | Hayden Jeremy B. | GC | S - Sale | $2.31 | -9,395 | 275,481 | -3% | -$21,693 | ||||||
2025-04-01 | SGHT | Sight Sciences, Inc. | Badawi Paul | Pres, CEO | S - Sale | $2.30 | -24,174 | 6,010,580 | 0% | -$55,673 | ||||||
2025-04-02 | SGHT | Sight Sciences, Inc. | Link Matthew | Chief Commercial Officer | S - Sale | $2.31 | -5,042 | 830,551 | -1% | -$11,642 | ||||||
2025-04-01 | SGHT | Sight Sciences, Inc. | Badawi David | CTO | S - Sale | $2.30 | -5,980 | 1,836,704 | 0% | -$13,772 | ||||||
2025-04-02 | SGHT | Sight Sciences, Inc. | Bauerlein Alison | CFO | S - Sale | $2.31 | -19,397 | 649,794 | -3% | -$44,788 | ||||||
2025-04-01 | RMD | Resmed Inc | Rider Michael J | Global GC | S - Sale | $222.86 | -64 | 8,846 | -1% | -$14,263 | ||||||
2025-03-31 | PEN | Penumbra Inc | Wilder Thomas | Dir | S - Sale | $264.58 | -360 | 5,610 | -6% | -$95,249 | ||||||
| D | 2025-04-01 | PEN | Penumbra Inc | Roberts Johanna | EVP, Gen. Counsel, Secretary | S - Sale+OE | $269.11 | -600 | 66,353 | -1% | -$161,466 | |||||
2025-04-01 | PEN | Penumbra Inc | Grewal Harpreet | Dir | S - Sale | $267.17 | -200 | 9,074 | -2% | -$53,434 | ||||||
| M | 2025-03-31 | SSII | Ss Innovations International, Inc. | Cohen Barry F | COO - Americas | P - Purchase | $9.66 | +3,090 | 8,842,570 | 0% | +$29,847 | |||||
2025-04-01 | NXGL | Nexgel, Inc. | Levy Adam R. | CEO | S - Sale | $3.01 | -4,000 | 370,284 | -1% | -$12,038 | ||||||
| D | 2025-04-01 | MMSI | Merit Medical Systems Inc | Peterson Neil | COO | S - Sale+OE | $104.53 | -5,000 | 28,369 | -15% | -$522,650 | |||||
| D | 2025-04-01 | BSX | Boston Scientific Corp | Mahoney Michael F | COB, Pres, CEO | S - Sale+OE | $100.01 | -164,442 | 1,796,008 | -8% | -$16,445,072 | |||||
2025-04-01 | PDEX | Pro Dex Inc | Cabillot Raymond E | Dir, 10% | S - Sale | $50.01 | -7,263 | 270,846 | -3% | -$363,223 | ||||||
2025-03-28 | CATX | Perspective Therapeutics, Inc. | Spoor Johan M. | CEO | P - Purchase | $2.24 | +26,676 | 87,683 | +44% | +$59,673 | ||||||
| M | 2025-02-28 | STSS | Sharps Technology Inc. | Hayes Robert Michael | CEO | P - Purchase | $0.04 | +300,000 | 400,882 | +297% | +$10,750 | |||||
| M | 2025-03-28 | CATX | Perspective Therapeutics, Inc. | Williamson Robert F III | Dir | P - Purchase | $2.19 | +60,337 | 109,348 | +123% | +$132,151 | |||||
2025-03-28 | CATX | Perspective Therapeutics, Inc. | Graham Juan | CFO | P - Purchase | $2.25 | +33,333 | 35,354 | >999% | +$74,946 | ||||||
2025-03-31 | CATX | Perspective Therapeutics, Inc. | Woods Lori A | Dir | P - Purchase | $2.13 | +23,475 | 188,267 | +14% | +$49,999 | ||||||
2025-03-28 | ALUR | Allurion Technologies, Inc. | Gaur Shantanu | CEO | P - Purchase | $3.35 | +8,000 | 70,032 | +13% | +$26,800 | ||||||
| M | 2025-03-28 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.70 | +24,004 | 15,982,322 | 0% | +$16,760 | |||||
| M | 2025-03-28 | PDEX | Pro Dex Inc | Cabillot Raymond E | Dir, 10% | S - Sale | $50.00 | -1,678 | 278,109 | -1% | -$83,900 | |||||
2025-03-27 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.74 | +6,736 | 15,958,318 | 0% | +$4,969 | ||||||
2025-03-25 | PEN | Penumbra Inc | Bose Arani | Dir | S - Sale | $283.77 | -12,000 | 314,819 | -4% | -$3,405,253 | ||||||
2025-03-26 | PDEX | Pro Dex Inc | Cabillot Raymond E | Dir, 10% | S - Sale | $50.13 | -3,096 | 279,787 | -1% | -$155,202 | ||||||
2025-03-25 | GKOS | Glaukos Corp | Thurman Alex R. | SVP, CFO | S - Sale | $106.84 | -1,520 | 53,431 | -3% | -$162,399 | ||||||
2025-03-25 | PODD | Insulet Corp | Frederick Wayne A.I. | Dir | S - Sale | $275.00 | -1,825 | 3,231 | -36% | -$501,875 | ||||||
2025-03-25 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.73 | +982 | 15,951,582 | 0% | +$718 | ||||||
| M | 2025-03-24 | PDEX | Pro Dex Inc | Cabillot Raymond E | Dir, 10% | S - Sale | $50.23 | -15,711 | 282,883 | -5% | -$789,157 | |||||
2025-03-24 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.72 | +751 | 15,950,600 | 0% | +$542 | ||||||
2025-03-24 | BVS | Bioventus Inc. | Singleton Mark Leonard | SVP, CFO | S - Sale | $9.79 | -5,479 | 131,963 | -4% | -$53,639 | ||||||
| D | 2025-03-20 | MODD | Modular Medical, Inc. | Manchester Management Co LLC | CEO, 10% | P - Purchase | $1.92 | +677,082 | 4,764,274 | +17% | +$1,299,997 | |||||
2025-03-21 | BSX | Boston Scientific Corp | Brown Vance R | SVP, GC, Corp. Secretary | S - Sale | $100.85 | -4,826 | 41,019 | -11% | -$486,702 | ||||||
| D | 2025-03-19 | PEN | Penumbra Inc | Elsesser Adam | CEO, Pres | S - Sale+OE | $276.21 | -16,600 | 865,334 | -2% | -$4,585,138 | |||||
2025-03-20 | LUNG | Pulmonx Corp | French Glendon E. III | Dir | S - Sale | $7.85 | -20,000 | 991,974 | -2% | -$157,000 | ||||||
| M | 2025-03-19 | PDEX | Pro Dex Inc | Cabillot Raymond E | Dir, 10% | S - Sale | $50.00 | -2,101 | 298,594 | -1% | -$105,050 | |||||
2025-03-18 | OFIX | Orthofix Medical Inc. | Vitale Lucas | CP, BOO | S - Sale | $16.60 | -4,287 | 135,317 | -3% | -$71,164 | ||||||
2025-03-18 | OFIX | Orthofix Medical Inc. | Gillespie Geoffrey C | CAO | S - Sale | $16.60 | -296 | 42,521 | -1% | -$4,914 | ||||||
2025-03-17 | MDXG | Mimedx Group, Inc. | Maersk-Moller Kimberly | Chief Commercial Officer | S - Sale | $8.04 | -1,759 | 309,077 | -1% | -$14,142 | ||||||
| D | 2025-03-17 | TMCI | Treace Medical Concepts, Inc. | Scanlan Sean F. | Chief Innovation Officer | S - Sale+OE | $7.97 | -50,000 | 364,081 | -12% | -$398,460 | |||||
2025-03-17 | DXCM | Dexcom Inc | Heller Bridgette P | Dir | S - Sale | $70.33 | -352 | 22,997 | -2% | -$24,756 | ||||||
2025-03-18 | PRCT | Procept Biorobotics Corp | Zadno Reza | Pres, CEO | S - Sale | $57.06 | -5,475 | 173,070 | -3% | -$312,404 | ||||||
2025-03-18 | PRCT | Procept Biorobotics Corp | Waters Kevin | EVP, CFO | S - Sale | $57.06 | -733 | 107,991 | -1% | -$41,825 | ||||||
2025-03-18 | PRCT | Procept Biorobotics Corp | Shiblaq Hisham | EVP, Chief Comm. Officer | S - Sale | $57.06 | -247 | 63,133 | 0% | -$14,094 | ||||||
2025-03-18 | PRCT | Procept Biorobotics Corp | Nouri Alaleh | EVP, CLO, CORP. SEC. | S - Sale | $57.06 | -316 | 61,473 | -1% | -$18,031 | ||||||
2025-03-18 | BDX | Becton Dickinson & Co | Byrd Richard | EVP, Pres Interventional | S - Sale | $230.00 | -459 | 6,952 | -6% | -$105,570 | ||||||
2025-03-14 | GUTS | Fractyl Health, Inc. | Royan Ajay | Dir, 10% | P - Purchase | $1.28 | +17,901 | 6,430,102 | 0% | +$22,980 | ||||||
2025-03-17 | BVS | Bioventus Inc. | Church Katrina J | SVP, Chief Compliance Officer | S - Sale | $9.75 | -1,018 | 52,540 | -2% | -$9,926 | ||||||
2025-03-17 | BVS | Bioventus Inc. | D'Adamio Anthony | SVP, GC | S - Sale | $9.75 | -2,615 | 124,449 | -2% | -$25,496 | ||||||
2025-03-14 | GUTS | Fractyl Health, Inc. | Barnes Kelly Ann | Dir | P - Purchase | $1.30 | +31,000 | 31,000 | New | +$40,210 | ||||||
2025-03-18 | KIDS | Orthopediatrics Corp | Gerritzen Daniel J | GC, Secretary | S - Sale | $24.86 | -5,310 | 110,767 | -5% | -$132,007 | ||||||
2025-03-18 | KIDS | Orthopediatrics Corp | Bailey David R | Pres, CEO | S - Sale | $24.86 | -6,620 | 319,155 | -2% | -$164,573 | ||||||
2025-03-18 | KIDS | Orthopediatrics Corp | Hite Fred | COO, CFO | S - Sale | $24.86 | -6,443 | 207,989 | -3% | -$160,173 | ||||||
2025-03-18 | KIDS | Orthopediatrics Corp | Odle Gregory A | Pres of Scoliosis | S - Sale | $24.86 | -5,359 | 148,788 | -3% | -$133,225 | ||||||
2025-03-18 | KIDS | Orthopediatrics Corp | Hauser Joseph W | Pres Trauma, Def. Correction | S - Sale | $24.86 | -5,300 | 137,663 | -4% | -$131,758 | ||||||
2025-03-14 | PDEX | Pro Dex Inc | Cabillot Raymond E | Dir, 10% | S - Sale | $50.00 | -5,151 | 300,695 | -2% | -$257,550 | ||||||
2025-03-13 | GUTS | Fractyl Health, Inc. | Schulman Amy W | Dir | P - Purchase | $1.17 | +8,550 | 8,550 | New | +$9,964 | ||||||
| M | 2025-03-13 | CERS | Cerus Corp | Jensen Chrystal | GC | S - Sale | $1.45 | -49,024 | 783,294 | -6% | -$71,085 | |||||
| M | 2025-03-13 | CERS | Cerus Corp | Jayaraman Vivek K | COO | S - Sale | $1.45 | -75,989 | 1,431,326 | -5% | -$110,184 | |||||
| M | 2025-03-13 | CERS | Cerus Corp | Greenman William Mariner | Pres, CEO | S - Sale | $1.45 | -193,913 | 4,115,845 | -4% | -$281,174 | |||||
| M | 2025-03-13 | CERS | Cerus Corp | Green Kevin Dennis | CFO | S - Sale | $1.45 | -59,887 | 875,867 | -6% | -$86,836 | |||||
| M | 2025-03-13 | CERS | Cerus Corp | Benjamin Richard J | Chief Medical Officer | S - Sale | $1.45 | -49,024 | 685,775 | -7% | -$71,085 | |||||
2025-03-13 | GUTS | Fractyl Health, Inc. | Bradley William | Dir | P - Purchase | $1.26 | +16,129 | 16,129 | New | +$20,358 | ||||||
2025-03-13 | GUTS | Fractyl Health, Inc. | Conaway Samuel | Dir | P - Purchase | $1.17 | +8,550 | 8,550 | New | +$9,964 | ||||||
2025-03-14 | XAIR | Beyond Air, Inc. | Carey Robert | Dir | P - Purchase | $0.25 | +1,000,000 | 5,553,490 | +22% | +$250,050 | ||||||
2025-03-13 | MDXG | Mimedx Group, Inc. | Hulse William Frank IV | GC, CAO | S - Sale | $7.89 | -54,596 | 440,178 | -11% | -$430,762 | ||||||
2025-03-13 | MDXG | Mimedx Group, Inc. | Maersk-Moller Kimberly | Chief Commercial Officer | S - Sale | $7.89 | -4,106 | 310,836 | -1% | -$32,396 | ||||||
2025-03-12 | DXCM | Dexcom Inc | Leach Jacob Steven | EVP, COO | S - Sale | $70.38 | -14,076 | 360,793 | -4% | -$990,670 | ||||||
2025-03-12 | DXCM | Dexcom Inc | Brown Michael Jon | EVP, GC | S - Sale | $70.38 | -13,000 | 105,602 | -11% | -$914,941 | ||||||
2025-03-12 | DXCM | Dexcom Inc | Sylvain Jereme M | EVP, Chief Financal Officer | S - Sale | $70.38 | -12,001 | 123,481 | -9% | -$844,632 | ||||||
2025-03-12 | DXCM | Dexcom Inc | Stern Sadie | EVP, CHRO | S - Sale | $70.38 | -11,176 | 115,805 | -9% | -$786,568 | ||||||
2025-03-12 | DXCM | Dexcom Inc | Sayer Kevin R | COB, CEO, Pres | S - Sale | $70.38 | -32,498 | 372,029 | -8% | -$2,287,212 | ||||||
| DM | 2025-03-12 | LMAT | Lemaitre Vascular Inc | Kamke Trent G | Senior V. P., Operations | S - Sale+OE | $80.42 | -6,529 | 3,753 | -63% | -$525,053 | |||||
| M | 2025-03-12 | SGHT | Sight Sciences, Inc. | Raheja Manohar K. | EVP, Research, Development | P - Purchase | $2.66 | +20,000 | 155,000 | +15% | +$53,250 | |||||
2025-03-13 | FNA | Paragon 28, Inc. | Mvm Partners, LLC | 10% | S - Sale | $13.04 | -1,044,295 | 7,810,588 | -12% | -$13,618,129 | ||||||
2025-03-12 | BDX | Becton Dickinson & Co | Byrd Richard | EVP, Pres Interventional | S - Sale | $224.91 | -1,940 | 7,411 | -21% | -$436,325 | ||||||
| D | 2025-03-10 | MDXG | Mimedx Group, Inc. | Hulse William Frank IV | GC, CAO | S - Sale+OE | $7.80 | -81,446 | 494,774 | -14% | -$635,279 | |||||
2025-03-10 | ATEC | Alphatec Holdings, Inc. | Koning John Todd | CFO | S - Sale | $9.72 | -165,121 | 483,107 | -25% | -$1,604,976 | ||||||
2025-03-10 | ATEC | Alphatec Holdings, Inc. | Lish Scott | COO | S - Sale | $9.72 | -27,994 | 816,500 | -3% | -$272,102 | ||||||
| D | 2025-03-11 | AORT | Artivion, Inc. | Holloway Jean F | SVP, GC | S - Sale+OE | $23.61 | -18,020 | 197,184 | -8% | -$425,510 | |||||
| D | 2025-03-11 | AORT | Artivion, Inc. | Davis John E | Chief Commercial Officer | S - Sale+OE | $23.61 | -15,100 | 208,778 | -7% | -$356,549 | |||||
2025-03-10 | RMD | Resmed Inc | Sandercock Brett | CFO | S - Sale | $230.36 | -1,000 | 90,864 | -1% | -$230,360 | ||||||
| M | 2025-03-10 | PDEX | Pro Dex Inc | Cabillot Raymond E | Dir, 10% | S - Sale | $45.02 | -12,806 | 305,846 | -4% | -$576,578 | |||||
2025-03-10 | DXCM | Dexcom Inc | Sylvain Jereme M | EVP, Chief Financal Officer | S - Sale | $73.83 | -7,000 | 135,482 | -5% | -$516,830 | ||||||
2025-03-07 | TNDM | Tandem Diabetes Care Inc | Kyrillos Jean-Claude | EVP, COO | P - Purchase | $18.12 | +10,538 | 10,538 | New | +$190,966 | ||||||
2025-03-10 | NXGL | Nexgel, Inc. | Henry Scott Robert | Dir | S - Sale | $2.87 | -3,000 | 138,053 | -2% | -$8,621 | ||||||
| D | 2025-03-10 | RMD | Resmed Inc | Ghoshal Kaushik | Chief Commercial Officer, SaaS | S - Sale+OE | $239.31 | -9,745 | 19,353 | -33% | -$2,332,096 | |||||
| D | 2025-03-07 | RMD | Resmed Inc | Farrell Michael J. | CEO | S - Sale+OE | $229.20 | -8,009 | 457,562 | -2% | -$1,835,692 | |||||
2025-03-07 | CERS | Cerus Corp | Jensen Chrystal | GC | S - Sale | $1.50 | -27,457 | 832,318 | -3% | -$41,131 | ||||||
2025-03-07 | CERS | Cerus Corp | Jayaraman Vivek K | COO | S - Sale | $1.50 | -33,999 | 1,507,315 | -2% | -$50,931 | ||||||
2025-03-07 | CERS | Cerus Corp | Greenman William Mariner | Pres, CEO | S - Sale | $1.50 | -60,984 | 4,309,758 | -1% | -$91,354 | ||||||
2025-03-07 | CERS | Cerus Corp | Green Kevin Dennis | CFO | S - Sale | $1.50 | -31,148 | 935,754 | -3% | -$46,660 | ||||||
2025-03-07 | CERS | Cerus Corp | Benjamin Richard J | Chief Medical Officer | S - Sale | $1.50 | -26,139 | 734,799 | -3% | -$39,156 | ||||||
| D | 2025-03-06 | AORT | Artivion, Inc. | Mackin James P | Pres, CEO | S - Sale+OE | $24.77 | -88,439 | 865,283 | -9% | -$2,190,848 | |||||
2025-03-06 | AORT | Artivion, Inc. | Horton Amy | VP, Chief Accounting Officer | S - Sale | $24.80 | -1,048 | 146,651 | -1% | -$25,995 | ||||||
2025-03-06 | AORT | Artivion, Inc. | Berry Lance A | EVP, CFO | S - Sale | $24.80 | -4,909 | 153,431 | -3% | -$121,764 | ||||||
2025-03-06 | AORT | Artivion, Inc. | Davis John E | Chief Commercial Officer | S - Sale | $24.80 | -2,618 | 207,968 | -1% | -$64,939 | ||||||
2025-03-06 | AORT | Artivion, Inc. | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale | $24.80 | -1,603 | 115,880 | -1% | -$39,761 | ||||||
2025-03-06 | AORT | Artivion, Inc. | Holloway Jean F | SVP, GC | S - Sale | $24.80 | -2,124 | 196,112 | -1% | -$52,685 | ||||||
2025-03-06 | PRCT | Procept Biorobotics Corp | Nouri Alaleh | EVP, CLO, CORP. SEC. | S - Sale | $61.31 | -3,641 | 61,789 | -6% | -$223,230 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |